Patents by Inventor Huiqing Liu

Huiqing Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230220478
    Abstract: Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
    Type: Application
    Filed: December 28, 2022
    Publication date: July 13, 2023
    Inventors: Michael D. Howell, Sherry Owens, Beth Rumberger, Huiqing Liu
  • Patent number: 11624751
    Abstract: Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: April 11, 2023
    Assignee: Incyte Corporation
    Inventors: Michael D. Howell, Sherry Owens, Beth Rumberger, Huiqing Liu
  • Patent number: 11584961
    Abstract: Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing an inflammatory skin disease.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: February 21, 2023
    Assignee: Incyte Corporation
    Inventors: Michael D. Howell, Huiqing Liu
  • Publication number: 20200348313
    Abstract: Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
    Type: Application
    Filed: March 18, 2020
    Publication date: November 5, 2020
    Inventors: Michael D. Howell, Sherry Owens, Beth Rumberger, Huiqing Liu
  • Publication number: 20200063188
    Abstract: Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing an inflammatory skin disease.
    Type: Application
    Filed: March 29, 2019
    Publication date: February 27, 2020
    Inventors: Michael D. Howell, Huiqing Liu
  • Patent number: D905781
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: December 22, 2020
    Inventor: Huiqing Liu